A 69-year-old man with heterozygote factor V Leiden mutation and a history of central retinal vein occlusion in his left eye complained of decreased visual acuity in his right eye. Macular edema and ischemic CRVO were diagnosed. Following an intravitreal injection of 4 mg triamcinolone acetonide, endophthalmitis and necrotizing retinopathy developed, clinically resembling necrotizing herpetic retinopathies as have been described in immuno-compromised patients. An endogenous viral infection due to a steroid-induced immune suppression may be another complication of intravitreal injections of corticosteroids.

Keywords:
Endophthalmitis, Intravitreal triamcinolone acetonide, Herpes
1.
Ip M, Kahana A, Altaweel M: Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 2003;18:67–73.
2.
Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J: Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765–772.
3.
Mennel S, Meyer CH, Schmidt JC, Rodrigues EB: Dreidimensionale Optische Kohärenz-Tomographie (3D-OCT) zur Verlaufskontrolle von Makulaödemen nach intravitrealer Triamcinolon Applikation. Spektrum Augenheilkd 2004;18:48–54.
4.
Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP, Kaiser RS, Bakri SJ, Maturi RK, Belmont J, Beer PM, Murray TG, Quiroz-Mercado H, Mieler WF: Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791–796.
5.
Benz MS, Glaser JS, Davis JL: Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids. Am J Ophthalmol 2003;135:551–553.
6.
Browning DJ: Acute retinal necrosis following epidural steroid injections. Am J Ophthalmol 2003;136:192–194.
7.
Nishiuchi T, Shiota H, Ishimaru H, Katayama T, Bando Y, Tani H, Shimoe C: Histopathological studies of a case of cytomegalovirus retinochoroiditis. Jpn J Ophthalmol 1992;36:175–183.
8.
The Central Vein Occlusion Study Group: Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486–491.
9.
Nishimura A, Kobayashi A, Segawa Y, Sakurai M, Shirao E, Shirao Y, Sugiyama K: Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 2003;23:777–779.
10.
Knox CM, Chandler D, Short GA, Margolis TP: Polymerase chain reaction-based assays of vitreous samples for the diagnosis of viral retinitis: use in diagnostic dilemmas. Ophthalmology 1998;105:37–44.
11.
Guex-Crosier Y, Rochat C, Herbort CP: Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm 1997;5:259–265.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.